Pancreatic Tumor Resection
Pancreatic Tumor Resection - Related Videos
10:10
Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
0 Views •
2026
This protocol presents robotic duodenum-preserving total pancreatic head resection (R-DPPHRt) for intraductal papillary mucinous neoplasms (IPMNs). A video demonstrates the technique in a patient with main duct-IPMN, highlighting its feasibility as a minimally invasive, organ-preserving alternative to pancreaticoduodenectomy.
03:58
Brain Tumor Resection in a Mouse Using a Minimally Invasive Resection System
0 Views •
2025
Source: Alomari, S., et al. Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection. J. Vis. Exp. (2022)This video demonstrates the use of a minimally invasive resection system (MIRS) to excise tumor tissue from an anesthetized mouse implanted with a tumor. The procedure involves securing the mouse onto a stereotactic frame, reopening the previous surgical site to access the brain, and inserting a specialized cannula that utilizes suction and a...
05:11
Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
0 Views •
2026
This article presents laparoscopic central pancreatectomy with pancreatic duct end-to-end anastomosis as an important surgical approach for middle-segment pancreatic benign and low-grade malignant tumors.
07:55
The Influence of Liver Resection on Intrahepatic Tumor Growth
0 Views •
Cited by 6 •
2016
A high incidence of tumor recurrence after resection of liver metastases remains an unsolved problem. The illustrated mouse model may be useful to investigate the reasons for such recurrences. It combines a liver resection model with intrahepatic tumor cell injection for the first time.
03:59
Orthotopic Homograft Tumor Transplantation: A Technique to Generate Pancreatic Tumor Mouse Models
0 Views •
2023
The video explains a stepwise surgical method for orthotopic implantation of a tumor fragment from a cancerous donor to the pancreas of a non-cancerous recipient mice for development of pancreatic cancer. Orthotopically implanted PDAC could recapture the tissue microenvironment of human pancreatic cancers than conventional subcutaneous (SC) models more accurately.
FAQs
The tumor’s position within the pancreas and its relationship to major vessels and ducts help determine the operative plan. Lesions in different regions may require pancreaticoduodenectomy or distal pancreatectomy, while the extent of nearby tissue removal depends on the observed anatomy. This assessment helps surgeons pursue complete treatment while accounting for technical complexity.
Pathological examination provides definitive assessment of the removed neoplasm and regional lymph nodes. The findings contribute to disease staging, which describes the extent of disease more precisely than operative appearance alone. Staging information can then guide decisions about additional therapy and helps characterize the significance of the surgical findings for subsequent medical management.
Potential benefit is greatest when disease is sufficiently localized for the tumor to be removed with an appropriate operation. Selection therefore considers the tumor’s location, its relationship to major vessels and ducts, and the patient’s ability to undergo major surgery. This balance is important because pancreatic resection carries substantial perioperative risks even when treatment is potentially curative.
The team first identifies the tumor and evaluates its relationship to nearby vessels and ducts during the operation. Surgeons then remove the involved pancreatic region, the tumor, and adjacent tissue or regional lymph nodes when indicated by the planned procedure. If removal disrupts digestive continuity, reconstruction of the digestive tract is performed as needed.
The choice between pancreaticoduodenectomy and distal pancreatectomy primarily reflects where the neoplasm is located within the pancreas and which surrounding structures are involved. These operations represent different anatomic strategies rather than interchangeable procedures. Reviewing the tumor’s position and local relationships allows the operative team to select the approach that matches the disease distribution.
For selected patients with localized pancreatic cancer, resection can offer potentially curative treatment rather than disease control alone. It also supplies tissue for definitive pathological assessment and staging. Those results help determine whether additional therapy should follow surgery, while perioperative management addresses the substantial risks associated with pancreatic operations and supports recovery.